Sign In
Buy XENE
$53.46
+1.16 (+2.22%)
At Close: Jun 03, 2026
Global Xenon Gas Market Report 2024-2034: Aerospace & Aircraft Industry Emerges as the Leading Consumer, with Significant Usage in Satellite Propulsion. The healthcare industry, a sector witnessing ex
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
04:01pm, Wednesday, 05'th Jun 2024
VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present
VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azet
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
09:21am, Friday, 10'th May 2024
Xenon (XENE) reports better-than-expected first-quarter 2024 earnings. Its development programs for azetukalner in epilepsy and MDD are progressing well.
Polarean Imaging lands new hospital order for Xenon MRI System
03:32am, Friday, 10'th May 2024
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) announced its latest new order for a Xenon MRI System, from the University of Alabama at Birmingham (UAB) Hospital. The order from the hospital, a top-tier a
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
04:01pm, Thursday, 09'th May 2024
Phase 3 epilepsy program continues to progress with anticipated completion of patient enrollment in X-TOLE2 in late 2024 to early 2025
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
04:01pm, Wednesday, 08'th May 2024
VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present
Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference
09:02am, Wednesday, 08'th May 2024
Featured Company at Respiratory Innovation Summit to Jump Start Robust Presence Featured Company at Respiratory Innovation Summit to Jump Start Robust Presence
Polarean Imaging to showcase Xenon MRI at Respiratory Innovation Summit
02:42am, Wednesday, 08'th May 2024
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF), a leader in advanced MRI technology, has been selected as a featured company and poster presenter at the upcoming American Thoracic Society's 2024 Respirato
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
04:01pm, Tuesday, 07'th May 2024
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
01:01pm, Monday, 06'th May 2024
Xenon Pharmaceuticals (XENE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
04:01pm, Thursday, 02'nd May 2024
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first quart
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
08:30am, Tuesday, 16'th Apr 2024
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlightin
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
08:30am, Wednesday, 10'th Apr 2024
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present a
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
04:01pm, Thursday, 04'th Apr 2024
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present a
